Slide Shows


From Bumpkins to Beaches: The 10 Crappiest U.S. States To Do Business Cue the banjos -- the following states figure in the list of 10 Worst States for Business in America.

Biotech Stocks Facing FDA Decision In May Another busy month at the FDA is coming to an end, and it’s that time again to take a look at the upcoming action dates of approval, and panel review dates in May.

The 10 Best-Selling Drugs Of The Year Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV or HCV infections. According to insurance industry group America’s Health Insurance Programs or AHIP, drug spending in the U.S. is projected to rise to $590 billion by 2020 from $337 billion in 2015. Drug approvals by the U.S. Food and Drug Administration touched a 21-year high in 2017. Novel drug approvals by the FDA totaled 46 in 2017, up from 22 in the prior year. Novel drugs are new molecular entities or NMEs having chemical structures that have never been approved before.

Potential Treatments For Sickle Cell Disease Sickle cell disease, or SCD in short, refers to a group of inherited red blood cell disorders. In these patients, the hemoglobin protein present inside the red blood cells is abnormal, causing the RBCs to become rigid, sticky and "C" or sickle, shaped. The faulty hemoglobin is known as sickle hemoglobin (HbS), and is caused by a mutation. It is estimated that about 70,000 to 100,000 Americans have sickle cell disease.